Zing! This stock has had a slow leak since around $17
So is the stock!
Sentiment: Hold
Once the Linzess sales and IRWD earnings start rising we will see the mad rush to get in. Load up now
Yes, I should have. We closed today at 13.77.
Moronic target of $12, when he is predicting profitably, increasing scrips etc
What you did not mention is that he still maintains a $12 target.
Sentiment: Strong Sell
Not so fast. I believe IRWD still has millions of shares to sell at the open market.
The technicals for IRWD are looking pretty strong this morning. No.2 on NASDAQ 100 top buying list at nna100 website.
Are they done?
These are games that these analysts play......
Wedbush's Gregory Wade reverses course and upgrades Ironwood Pharmaceuticals (IRWD) to Neutral from Underperform — he downgraded the shares a little over a month ago after asking some pointed questions regarding R&D expenditures on the CC. Wade now says higher W/W script growth should lead to greater net sales of Linzess (IRWD disappointed with Linzess sales in Q1) which ultimately means a lower balance sheet gap to profitability ($150M versus $200M). Wade also says the company shouldn't need any more equity financing. Shares +1% premarket.
I missed it, but why did they need the money? They have a product that's now on the market.
To answer your question- it wasn't too hard when the price was 14 to make them think it was a deal.
Btw when did you cover your short position?
how does the company sell 10,500,000 shares of common stock to the public for $13 a share when the stock is trading under 13? I realize the general public isn't very smart but this I do not understand. Maybe I'm the dumb one? Someone please advise me. Thanks in advance
My spouse and I preferred to present this link with every body. This website has a newsletter with detailed info of hot small-cap stocks.
tinyDotcc/cax9uw
[Remove Dot and Use . ]
Agree. Read the Seeking alfa article on Synergy yesterday . The article in fact is more positive on Linzess and compares its growth to Zelnorm . Expects Linzess to be a blockbuster.Synergy drug is 3 years away and until then Linzess should have a great run.
This will be the last cash the company needs before they get profitable. Great opportunity to jump back in at this PPS.
This will prob stay around the 13 mark for a while, i wouldn't be in such a rush.
...until SGYP comes along and clobbers ya.
Sentiment: Strong Sell
Why not wait until drops some more?
Sentiment: Hold
The anticipated secondary offering was keeping the stock down.
Now if sales are good we should have a good run-up .
Sentiment: Strong Buy
Nice, informative post, way to contribute something.
Cheers!

Latest Business News: Dish Steps Down From Sprint Merger to Clear Way for Clearwire
Wochit - 7 hours ago
Banking Latest News: Dish Steps Down From Sprint Merger to Clear Way for Clearwire
Wochit - 7 hours ago